USFDA accepts for Priority review Bristol Myers Squibb application for CC-486 for maintenance treatment in leukemia Ruchika Sharma5 May 2020 9:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted it's New Drug Application (NDA) for...
Shilpa Medicare launches generic verision cancer drug Dasatinib at monthly therapy cost of Rs 6,440 Ruchika Sharma25 April 2020 12:44 PM ISTThe branded generic anti-cancer drug will be available in all dosage strengths of 20/ 50/ 70/ 100 mg tablets
SGLT2 inhibitors can lead to serious genital infection: USFDA warning Ruby Khatun Khatun31 Aug 2018 9:00 AM ISTThe SGLT2 inhibitors approved by the FDA include Johnson and Johnson's Invokana, Eli Lilly & Co's Jardiance, as well as those from Bristol-Myers...
AstraZeneca wins FDA breakthrough status for durvalumab savita thakur thakur18 Feb 2016 9:16 AM ISTLONDON: The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca's biggest new drug hope durvalumab as a...
Sanofi deepens cancer drive with two deals worth $1.2 billion, Innate jumps savita thakur thakur12 Jan 2016 9:24 AM ISTParis: Sanofi boosted its presence in cancer research by signing two deals with biotech companies worth up to $1.2 billion, as the French drugmaker...
New blood thinner antidote to help doctors move past warfarin savita thakur thakur25 Dec 2015 11:26 PM ISTBy Bill BerkrotNew York: A new class of blood thinners that competes with widely used warfarin should get a boost next year when an "antidote" that...
GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 mln savita thakur thakur19 Dec 2015 1:05 PM ISTLondon: Pharmaceutical group GlaxoSmithKline said its majority-owned HIV drugs business would buy drugs at different stages of development from U.S....
Syngene International to set $100-million manufacturing plant Pooja Bhatia Bhatia12 Dec 2015 10:36 AM ISTBiocon's custom research and manufacturing services arm, Syngene International, has announced its plan to launch a manufacturing unit at an investment...
FDA approves Empliciti to treat multiple myeloma Meghna A Singhania3 Dec 2015 12:35 PM ISTToday the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with...
FDA expands Merck drug's approval to treat lung cancer Meghna A Singhania4 Oct 2015 12:35 PM ISTWASHINGTON: Federal health officials have expanded approval of an innovative Merck drug to treat patients with an advanced form of the most common...
